XOMAO
Price:
$25.68
Market Cap:
$309.89M
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.[Read more]
Industry
Biotechnology
IPO Date
2021-04-12
Stock Exchange
NASDAQ
Ticker
XOMAO
According to XOMA Corporation’s latest financial reports and current stock price. The company's current ROE is -33.68%. This represents a change of 259.72% compared to the average of -9.36% of the last 4 quarters.
The mean historical ROE of XOMA Corporation over the last ten years is -9.97%. The current -33.68% ROE has changed 237.91% with respect to the historical average. Over the past ten years (40 quarters), XOMAO's ROE was at its highest in in the September 2017 quarter at 648.39%. The ROE was at its lowest in in the December 2015 quarter at -1097.96%.
Average
-9.97%
Median
-1.33%
Minimum
-1235.91%
Maximum
892.42%
Discovering the peaks and valleys of XOMA Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 233.68%
Maximum Annual ROE = 892.42%
Minimum Annual Increase = -223.86%
Minimum Annual ROE = -1235.91%
Year | ROE | Change |
---|---|---|
2023 | -46.02% | 233.68% |
2022 | -13.79% | -223.86% |
2021 | 11.14% | -27.63% |
2020 | 15.39% | -187.92% |
2019 | -17.50% | -75.36% |
2018 | -71.03% | -128.16% |
2017 | 252.26% | 122.48% |
2016 | 113.39% | -87.29% |
2015 | 892.42% | -172.21% |
2014 | -1235.91% | -139.72% |
The current ROE of XOMA Corporation (XOMAO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-16.23%
5-year avg
-10.16%
10-year avg
-9.97%
XOMA Corporation’s ROE is greater than XOMA Corporation (-33.68%), greater than Harrow Health, Inc. 8.625% Senior Notes due 2026 (-54.11%), less than SiriusPoint Ltd. (11.97%), less than New York Mortgage Trust, Inc. (0.06%), greater than Sachem Capital Corp. (-1.98%),
Company | ROE | Market cap |
---|---|---|
-33.68% | $304.35M | |
-54.11% | $1.20B | |
11.97% | $4.11B | |
0.06% | $2.27B | |
-1.98% | $751.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XOMA Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like XOMA Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is XOMA Corporation's ROE?
How is the ROE calculated for XOMA Corporation (XOMAO)?
What is the highest ROE for XOMA Corporation (XOMAO)?
What is the 3-year average ROE for XOMA Corporation (XOMAO)?
What is the 5-year average ROE for XOMA Corporation (XOMAO)?
How does the current ROE for XOMA Corporation (XOMAO) compare to its historical average?